CVS Health (CVS) director J. Scott Kirby receives 1,447-share stock retainer grant

Rhea-AI Filing Summary

KIRBY J SCOTT reported acquisition or exercise transactions in this Form 4 filing.

CVS Health director J. Scott Kirby received 1,447 shares of Common Stock as a grant on May 14, 2026. The shares were issued at a stated market price of $97.15 per share as payment of a semi-annual retainer under the 2017 Incentive Compensation Plan, bringing his direct holdings to 14,434 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider KIRBY J SCOTT

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,447	$97.15	$141K

Holdings After Transaction: Common Stock — 14,434 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares granted: 1,447 shares Grant price: $97.15 per share Shares after transaction: 14,434 shares +2 more

5 metrics

Shares granted 1,447 shares Common Stock grant on May 14, 2026

Grant price $97.15 per share Market price used for semi-annual retainer grant

Shares after transaction 14,434 shares Total direct holdings following grant

Transaction code A Grant, award, or other acquisition of Common Stock

Ownership type Direct (D) Reported as directly owned Common Stock

Key Terms

2017 Incentive Compensation Plan, semi-annual retainer, Common Stock, Grant, award, or other acquisition

4 terms

2017 Incentive Compensation Plan financial

"pursuant to the 2017 Incentive Compensation Plan."

semi-annual retainer financial

"issued in payment of a semi-annual retainer, at the market price"

Common Stock financial

"Consists of common stock issued in payment of a semi-annual retainer"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KIRBY J SCOTT

(Last) (First) (Middle)

ONE CVS DRIVE

(Street)

WOONSOCKET RHODE ISLAND 02895

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/14/2026		A(1)		1,447	A	$97.15	14,434	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

	/s/ J. Scott Kirby	05/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CVS (CVS) report for J. Scott Kirby?

CVS reported that director J. Scott Kirby acquired 1,447 shares of Common Stock. The shares were granted as part of his semi-annual retainer under the 2017 Incentive Compensation Plan at a stated market price of $97.15 per share.

Was the CVS (CVS) insider transaction an open-market purchase or a grant?

The transaction was a grant, not an open-market purchase. Shares were issued in payment of a semi-annual retainer under CVS Health’s 2017 Incentive Compensation Plan, classified as a grant, award, or other acquisition in the Form 4 data.

How many CVS (CVS) shares does J. Scott Kirby hold after this Form 4?

After receiving 1,447 shares, J. Scott Kirby directly holds 14,434 CVS Common Stock shares. This post-transaction balance reflects the addition from the semi-annual retainer grant disclosed in the Form 4 filing data.

What price was used for the CVS (CVS) stock grant to J. Scott Kirby?

The grant used a market price of $97.15 per share. The footnote explains the common stock was issued in payment of a semi-annual retainer at the market price under the 2017 Incentive Compensation Plan.

What plan governs the CVS (CVS) stock grant reported for J. Scott Kirby?

The stock grant was made under CVS Health’s 2017 Incentive Compensation Plan. The footnote states the common stock was issued as payment of a semi-annual retainer at the market price pursuant to this plan.